Cite
HARVARD Citation
Kosiborod, M. et al. (2022). Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial. Circulation. 146 (4), pp. 279-288. [Online].